Skip to content

Search for Studies

Search Results

It is unknown whether passive myofunctional appliances can be used for the treatment of obstructive sleep apnea and snoring, nor how to select the appropriate size per individual patient. Exploring the possibility of using passive myofunctional appliances as a treatment option for patients with mild obstructive sleep apnea and/or snoring should be considered, especially as the time to fabricate and deliver custom designed dental sleep appliances can be significant (sometimes over a month). Use of passive myofunctional appliances as a transitional appliance or potentially as direct treatment for obstructive sleep apnea may significantly decrease time to treatment and also provide a less expensive treatment option for patients with obstructive sleep apnea. The purpose of this study is to determine whether passive myofunctional appliances can be used as a treatment option for patients suffering from snoring and mild obstructive sleep apnea (OSA).

Conditions:
Sleep Apnea, Obstructive
Location:
  • Enjoy Dental, Edmonton, Alberta, Canada
Sex:
ALL
Ages:
Over 18

This is a phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).

Conditions:
Traumatic Brain Injury
Location:
  • Vancouver General Hospital, Vancouver, British Columbia, Canada
  • The Ottawa Hospital, Ottawa, Ontario, Canada
  • University of Alberta Hospital, Edmonton, Alberta, Canada
  • Kingston General Hospital, Kingston, Ontario, Canada
  • Royal University Hospital, Saskatoon, Saskatchewan, Canada
  • Foothills Medical Centre, Calgary, Alberta, Canada
  • Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
  • Sunnybrook Health Science Centre, Toronto, Ontario, Canada
  • Royal Alexandra Hospital, Edmonton, Alberta, Canada
  • Hamilton Health Sciences Centre, Hamilton, Ontario, Canada
  • Unity Health Toronto, Toronto, Ontario, Canada
Sex:
ALL
Ages:
Over 18

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major adverse cardiovascular event (MACE) (the composite of cardiovascular \[CV\] death, myocardial infarction \[MI\], and ischemic stroke).

Conditions:
Acute Coronary Syndrome
Location:
  • Foothills Hospital, Calgary, Alberta, Canada
  • Saint Boniface General Hospital, Winnipeg, Manitoba, Canada
  • London Health Sciences Centre, London, Ontario, Canada
  • Kawartha Cardiology Clinical Trials, Peterborough, Ontario, Canada
  • Clinique de Cardiologie de Levis, Levis, Quebec, Canada
  • CSSS du Sud de Lanaudiere - Hopital Pierre-Le Gardeur d/b/a CISSS de Lanaudiere, Terrebonne, Quebec, Canada
  • Vancouver General Hospital, Vancouver, British Columbia, Canada
  • Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
  • University of Ottawa Heart Institute, Ottawa, Ontario, Canada
  • Office of Dr. Anthony Glanz, Windsor, Ontario, Canada
  • CardioVasc HR, St Jean sur Richelieu, Quebec, Canada
  • University of Alberta, Edmonton, Alberta, Canada
  • Dalhousie University, Halifax, Nova Scotia, Canada
  • Southlake Regional Health Centre, Newmarket, Ontario, Canada
  • Niagara Health System, St Catharines, Ontario, Canada
  • Centre de Recherche du CHUM, Montreal, Quebec, Canada
  • CIUSSS de la Mauricie-et-du-Centre-du-Quebec, Trois-Rivières, Quebec, Canada
  • Surrey Memorial Hospital, Surrey, British Columbia, Canada
  • Dr. Saul Vizel Cardiac Research Office, Cambridge, Ontario, Canada
  • Halton Healthcare Services Corporation, Oakville, Ontario, Canada
  • Toronto Sunnybrook Hospital, Toronto, Ontario, Canada
  • Montreal General Hospital, Montreal, Quebec, Canada
  • Royal University Hospital, Saskatoon, Saskatchewan, Canada
Sex:
ALL
Ages:
Over 18

A randomized, double-blind, placebo-controlled multicenter, phase 3 study to evaluate the efficacy and safety of tezepelumab administered subcutaneously (SC) using an accessorized pre-filled syringe (APFS) versus placebo in adult and adolescent patients with eosinophilic esophagitis (EoE).

Conditions:
Eosinophilic Esophagitis
Location:
  • Research Site, Windsor, Ontario, Canada
  • Research Site, Hamilton, Ontario, Canada
  • Research Site, Ottawa, Ontario, Canada
  • Research Site, Montreal, Quebec, Canada
  • Research Site, London, Ontario, Canada
  • Research Site, Niagara Falls, Ontario, Canada
Sex:
ALL
Ages:
12 - 80

The goal of the study is to evaluate the acceptability and feasibility of a co-designed, Technology-Enabled Collaborative Care for Young Adults with Type-1 Diabetes and Diabetes Distress (TECC-T1D3) program. Through this program, the investigators aim to deliver a collaborative care intervention, featuring a health coach and a virtual care team, designed to help participants manage mental health and overall wellbeing.

Conditions:
Type 1 Diabetes (T1D) | Diabetes Distress
Location:
  • Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Sex:
ALL
Ages:
18 - 29

The goal of this study is to test the effect of a probiotic formulation on gastrointestinal symptoms, gut and small intestine microbiota in participants suffering from small intestinal bacterial overgrowth (SIBO). Two doses of probiotic will be evaluated against placebo.

Conditions:
Small Intestinal Bacterial Overgrowth | SIBO
Location:
  • Nimble Science, Calgary, Alberta, Canada
Sex:
ALL
Ages:
18 - 55

The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).

Conditions:
Multiple Myeloma
Location:
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada
  • Cross Cancer Institute, Edmonton, Alberta, Canada
  • Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
Sex:
ALL
Ages:
Over 18

This project proposes to compare epidural versus spinal anesthesia in patients having liver resection surgery. The investigators hypothesize that spinal anesthesia will result in improved blood pressure control postoperatively and reduce the amount of intravenous fluids required after surgery. Spinal anesthesia is expected to provide the same pain control benefits as epidurals, with faster recovery of function. Spinal anesthesia may be a simple and effective way to improve and enhance the recovery in the increasing number of patients requiring liver resection.

Conditions:
Pain, Postoperative | Liver Neoplasms | Hepatectomy
Location:
  • University of Manitoba, Winnipeg, Manitoba, Canada
Sex:
ALL
Ages:
Over 18

The investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity of the procedure

Conditions:
Prostate Cancer | Erectile Dysfunction
Location:
  • Jewish General Hospital, CIUSSS Centre-Ouest de l'île de Montréal, Montreal, Quebec, Canada
  • Jewish General Hospital, Montréal, Quebec, Canada
Sex:
MALE
Ages:
Over 18

Anterior cruciate ligament (ACL) ruptures are very common knee injuries amongst youth involved in sports and are often treated through ACL reconstruction surgeries. Unfortunately, up to 50% of individuals who undergo ACL reconstruction develop post-traumatic osteoarthritis (PTOA) in their injured knee by 20 years post-reconstruction causing pain, decreasing mobility, and impacting quality of life in young active individuals. Much remains unknown regarding the secondary prevention of PTOA, and more investigation is necessary to better understand its disease progression post-ACL reconstruction and types of conservative interventions that can prevent or delay its onset. Physical activity has improved patient-reported outcomes across many different chronic diseases including knee osteoarthritis (OA), and physical activity prescription has been shown to be an effective way to increase patients' levels of physical activity. It has not yet been heavily investigated in the context of post-ACL reconstruction, and individuals often exhibit decreased physical activity after ACL reconstruction which causes suboptimal cartilage health. Thus, physical activity prescription may improve habitual joint loading, leading to improved cartilage health and patient-reported health outcomes.

Conditions:
Post-traumatic Osteoarthritis | ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION
Location:
  • Fowler Kennedy Sport Medicine Clinic, London, Ontario, Canada
Sex:
ALL
Ages:
21 - 32